Sống đẳng cấp căn hộ hạng sang ven Hồ Tây với Sunshine anninhthudo.vn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from anninhthudo.vn Daily Mail and Mail on Sunday newspapers.
Sunshine Homes chiếm trọn làn sóng bất động sản hạng sang Tây Hồ Tây với 600 villas đẳng cấp kinhtedothi.vn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kinhtedothi.vn Daily Mail and Mail on Sunday newspapers.
Published: May 01, 2021
Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia
BOSTON, May 1, 2021 /PRNewswire/ Chiesi Global Rare Diseases, a business unit of
Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today that the U.S. Food & Drug Administration (FDA) has approved FERRIPROX
® (deferiprone) for the treatment of transfusional iron overload due to sickle cell disease (SCD) or other anemias in adult and pediatric patients 3 years of age and older. This FDA approval expands the use of FERRIPROX for patients with SCD or other anemias as well as patients with thalassemia regardless of prior iron chelation exposure.
Điện kính thiên Còn nhiều dấu hỏi nghiên cứu về kinh đô hoa lệ nghìn năm thethaovanhoa.vn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thethaovanhoa.vn Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group),.